ODI Pharma

ODI Pharma

Pressreleases, rapporter och nyheter för ODI Pharma

Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Comment to the founders" sale of shares
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Aphria Inc. received its EU-GMP certification
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Idag inleds handeln i ODI Pharmas aktier på Spotlight Stock Market
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: The trade in ODI Pharma AB"s shares on Spotlight Stock Market commences today
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Market Notices: Market Notice 15/20 - ODI Pharma AB will be listed on Spotlight Stock Market on January 23, 2020
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Slutlig registrering av ODI Pharmas nyemission genomförd
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Final registration of ODI Pharma"s new share issue completed
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Korrigering-Delregistrering av ODI Pharmas nyemission genomförd
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Correction-First registration of ODI Pharma"s new share issue completed
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: Delregistrering av ODI Pharmas nyemission genomförd
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: First registration of ODI Pharma"s new share issue completed
Spotlight News profile image
Spotlight News
Nyhetsuppdatering från ODI Pharma
Press release from Companies: ODI Pharmas nyemission inför notering kraftigt övertecknad
Loading...